DK165785A - Immunometrisk bestemmelse rettet mod flere steder - Google Patents

Immunometrisk bestemmelse rettet mod flere steder Download PDF

Info

Publication number
DK165785A
DK165785A DK165785A DK165785A DK165785A DK 165785 A DK165785 A DK 165785A DK 165785 A DK165785 A DK 165785A DK 165785 A DK165785 A DK 165785A DK 165785 A DK165785 A DK 165785A
Authority
DK
Denmark
Prior art keywords
labelled
antigen
antibody
complex
soluble
Prior art date
Application number
DK165785A
Other languages
English (en)
Other versions
DK165785D0 (da
Inventor
Jack R Wands
Dominique Bellet
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of DK165785D0 publication Critical patent/DK165785D0/da
Publication of DK165785A publication Critical patent/DK165785A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
DK165785A 1984-04-12 1985-04-12 Immunometrisk bestemmelse rettet mod flere steder DK165785A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59956084A 1984-04-12 1984-04-12

Publications (2)

Publication Number Publication Date
DK165785D0 DK165785D0 (da) 1985-04-12
DK165785A true DK165785A (da) 1985-10-13

Family

ID=24400127

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165785A DK165785A (da) 1984-04-12 1985-04-12 Immunometrisk bestemmelse rettet mod flere steder

Country Status (6)

Country Link
EP (1) EP0158973B1 (da)
JP (1) JPS60259963A (da)
AT (1) ATE57018T1 (da)
DE (2) DE3579841D1 (da)
DK (1) DK165785A (da)
GR (1) GR850899B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101492A1 (en) 2003-05-19 2004-11-25 Orion Corporation Toremifene crystallization method

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
JPS63127160A (ja) * 1986-06-30 1988-05-31 Sukeyasu Yoneda 特異的蛋白質の検出方法
US4804626A (en) * 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
JP2515533B2 (ja) * 1987-02-23 1996-07-10 和光純薬工業株式会社 蛋白の定量方法
US5506150A (en) * 1987-07-09 1996-04-09 3I Research Exploitation Limited Prenatal screening for down's syndrome
EP0362294B1 (en) * 1987-07-09 1993-06-30 3i RESEARCH EXPLOITATION LIMITED Antenatal screening for down's syndrome
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
ES2210266T3 (es) * 1989-01-17 2004-07-01 Jn Macri Technologies Llc Aparato para detectar el sindrome de down por medio de un examen no invasivo de sangre materna.
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
ATE331952T1 (de) * 1994-07-25 2006-07-15 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
DE19534988A1 (de) * 1995-09-21 1997-03-27 Forssmann Wolf Georg Verfahren zur Herstellung und Anwendung synthetischer, biotinylierter Peptide
US7060437B1 (en) 1999-05-05 2006-06-13 Ohio University Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof
CA2370134A1 (en) * 1999-05-05 2000-11-09 Ohio University Growth hormone-regulatable liver genes and proteins, and uses thereof
US6858389B1 (en) 1999-05-05 2005-02-22 Ohio University Growth hormone-regulatable liver genes and proteins, and uses thereof
US20030180967A1 (en) * 2002-03-19 2003-09-25 Matsushita Electric Industrial Co., Ltd. Immunoassay method, test strip for use therein, and immunoassay apparatus
AU2003248982B2 (en) * 2002-08-01 2009-12-10 Immunomedics, Inc. Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
CN105572358A (zh) * 2014-10-09 2016-05-11 苏州新波生物技术有限公司 乙型肝炎病毒e抗原定量检测试剂盒及其制备与检测方法
CN104714015B (zh) * 2014-10-28 2017-05-17 威海纽普生物技术有限公司 心型脂肪酸结合蛋白检测试剂盒及检测方法
CN104714033B (zh) * 2014-11-28 2017-03-15 威海纽普生物技术有限公司 降钙素原检测试剂盒及检测方法
CN104730251B (zh) * 2014-11-28 2016-11-23 威海纽普生物技术有限公司 肌钙蛋白i检测试剂盒及检测方法
CN104714025B (zh) * 2014-11-28 2017-05-17 威海纽普生物技术有限公司 NT‑proBNP检测试剂盒及检测方法
CN104730245B (zh) * 2014-11-28 2016-09-28 威海纽普生物技术有限公司 D二聚体检测试剂盒及检测方法
CN110234995A (zh) * 2017-02-02 2019-09-13 豪夫迈·罗氏有限公司 使用至少两种聚乙二醇化的分析物特异性结合试剂的免疫测定
CN106970226A (zh) * 2017-03-22 2017-07-21 童坤 一种测定人血清中her‑2 ecd浓度水平的试剂盒
MX2020003193A (es) * 2017-09-22 2020-07-29 Hoffmann La Roche Anticuerpos recombinantes mono- o biespecificos multivalentes para fines analiticos.
JP7313659B2 (ja) * 2019-03-12 2023-07-25 株式会社シノテスト 試料中のｈｍｇｂ１の測定方法及び測定試薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
SE8006424L (sv) * 1980-09-12 1982-03-13 Jolla Cancer Res Found Sett att bestemma ett antigen i losning
JPS57136165A (en) * 1981-02-18 1982-08-23 Mochida Pharmaceut Co Ltd Immunological measuring reagent
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101492A1 (en) 2003-05-19 2004-11-25 Orion Corporation Toremifene crystallization method
US7368607B2 (en) * 2003-05-19 2008-05-06 Orion Corporation Toremifene crystallization method

Also Published As

Publication number Publication date
JPS60259963A (ja) 1985-12-23
GR850899B (da) 1985-11-25
EP0158973B1 (en) 1990-09-26
ATE57018T1 (de) 1990-10-15
EP0158973A2 (en) 1985-10-23
EP0158973A3 (en) 1988-01-07
DE3579841D1 (de) 1990-10-31
DK165785D0 (da) 1985-04-12
DE158973T1 (de) 1987-01-15

Similar Documents

Publication Publication Date Title
DK165785A (da) Immunometrisk bestemmelse rettet mod flere steder
EP0315364A3 (en) Simultaneous immunoassay for the determination of antigens and antibodies
IL88248A (en) Solid phase immunoassay for detecting hiv antigens using kc-57 monoclonal antibody, and kit for the performance thereof
FI970301A (fi) Spesifisen immunoglobuliinin määrittäminen käyttäen useampaa antigeenia
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
EP0310132A3 (en) Immunoassay utilizing igg capture antibody and multiple monoclonal antibody detection system
ES551494A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivos con antigenos de esporozoitos o merozoitos de eimeria spp.
EP0383313A3 (en) Reagent for immunoassay, and kit containing the same
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
ES520012A0 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
FI874280A0 (fi) Immunometriskt bestaemningsfoerfarande.
DE3687487D1 (de) Monoklonaler antikoerper, spezifisch fuer ein pigmentationassoziiertes antigen.
EP0271810A3 (en) Immunological determination of free human protein s and c4bp-protein s complex
ES2126608T3 (es) Procedimiento para la determinacion de antigenos o anticuerpos en presencia de un inmunocomplejo.
FI882019A0 (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
DE68919521T2 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
DE3478346D1 (en) Method for assaying basic fetoprotein and reagent therefor
FI904304A0 (fi) Foerfarande foer paovisande av analyter.
EP0339632A3 (en) Method of assaying human cancer antigens
GR3002434T3 (en) Immunoassay
KR880000794A (ko) 샌드위치식 면역분석용 시약 복합물

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment